Search

everythinglearnresearchcommunity

for

Search:↓

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Follicular Unit Transplantation (FUT) can give great results and patient satisfaction when done carefully and by a skilled surgeon.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

A faulty KLHL24 gene leads to hair loss by damaging hair follicle stem cells.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

The hair loss in Belgian Blue crossbred calves was caused by a diet issue, not by disease or infection.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

Androgenetic alopecia negatively affects emotions and self-confidence, especially in younger people.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Female pattern hair loss treatments vary in effectiveness and may have side effects.